TRUBION PHARMACEUTICALS INC. TRBN (NASDAQ)

$ 1.29
12/01/2008 20:09
Sponsored by
Click here!
Change: -0.04 (-3.01%)
Volume: 43,300

Avg. Volume: 16070
P/E Ratio: 0
EPS (Annual): -1.35
Profit Margin:
Dividend & Yield(Annual): 0%
Shares Outstanding: 17,860
Institutional Shareholders: 31.72%
Last: 1.29
Change: -0.04 (-3.01%)
Prev. Close: 1.33
Open: 1.18
Day's Range: 1.18 - 1.34
52wk Range: 1.04 - 12.60
Market Value: 22,320
Beta:
12-month EPS Change: 0.00%
Total Return Last 12 Months: -86.69%
Total Return Last 3 Years: -117.72%
Total Return Last 5 Years: -89.84%
5-Year Revenue Growth Rate: 0.00%
5-Year Dividend Growth Rate: 0.00%
5-Year EPS Growth Rate: 0.00%


Headlines on TRBN
Alert me Subscribe

Trubion says Wyeth extends research collaboration

(SEATTLE)Biopharmaceutical company Trubion Pharmaceuticals Inc. said Thursday Wyeth the companies' research partnership for an additional year, resulting in $3.2 million of additional f...READ MORE
Jun 20, 2008 11:04AM
Keywords: TRBN, WYE
RSS Page | Sign up for Google Alerts


Data Provided By Barchart.com
advertisement

Top Competitors

AMGEN INC. +7.80 54.77
GILEAD SCIENCES -16.80 42.46
CELGENE CORPORA -26.90 47.82
GENENTECH INC -4.90 71.80
GENZYME CORPORA -28.20 57.70